EP2596131A4 - Genexpressionsanalysen zur identifikation von lungenkrebs - Google Patents

Genexpressionsanalysen zur identifikation von lungenkrebs

Info

Publication number
EP2596131A4
EP2596131A4 EP11810327.4A EP11810327A EP2596131A4 EP 2596131 A4 EP2596131 A4 EP 2596131A4 EP 11810327 A EP11810327 A EP 11810327A EP 2596131 A4 EP2596131 A4 EP 2596131A4
Authority
EP
European Patent Office
Prior art keywords
identification
gene expression
lung cancer
expression profiling
copd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11810327.4A
Other languages
English (en)
French (fr)
Other versions
EP2596131A2 (de
Inventor
Karl Wassmann
Danute M Bankaitis-Davis
Kathleen Storm
Lisa Siconolfi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DxTerity Diagnostics
Original Assignee
DxTerity Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DxTerity Diagnostics filed Critical DxTerity Diagnostics
Publication of EP2596131A2 publication Critical patent/EP2596131A2/de
Publication of EP2596131A4 publication Critical patent/EP2596131A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP11810327.4A 2010-07-21 2011-07-20 Genexpressionsanalysen zur identifikation von lungenkrebs Withdrawn EP2596131A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36633110P 2010-07-21 2010-07-21
PCT/US2011/044648 WO2012012510A2 (en) 2010-07-21 2011-07-20 Gene expression profiling for the identification of lung cancer

Publications (2)

Publication Number Publication Date
EP2596131A2 EP2596131A2 (de) 2013-05-29
EP2596131A4 true EP2596131A4 (de) 2013-12-18

Family

ID=45497433

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11810327.4A Withdrawn EP2596131A4 (de) 2010-07-21 2011-07-20 Genexpressionsanalysen zur identifikation von lungenkrebs

Country Status (2)

Country Link
EP (1) EP2596131A4 (de)
WO (1) WO2012012510A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6240804B1 (ja) * 2017-04-13 2017-11-29 大▲連▼大学 改良した情報測定とｇａに基づくフィルター式特徴選択アルゴリズム
CN110699457B (zh) * 2019-10-30 2022-11-25 深圳瑞科生物科技有限公司 检测肺癌的引物组和试剂盒

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080597A1 (en) * 2005-01-31 2006-08-03 Digital Genomics Inc. Markers for the diagnosis of lung cancer
WO2008063413A2 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006080597A1 (en) * 2005-01-31 2006-08-03 Digital Genomics Inc. Markers for the diagnosis of lung cancer
WO2008063413A2 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer

Also Published As

Publication number Publication date
WO2012012510A2 (en) 2012-01-26
EP2596131A2 (de) 2013-05-29
WO2012012510A3 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
EP2591357A4 (de) Biomarker für lungenkrebs und verwendung
CY1122247T1 (el) Αγωγη καρκινων με τη χρηση τροποποιητων ισομορφης κινασης ρι3
SG10202001482YA (en) Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers
IL252163A0 (en) Lung cancer biomarkers and uses thereof
IL257330B (en) Compositions, methods and kits for diagnosis of lung cancer
EP3607089A4 (de) Plasmabasierte proteinprofilierung für lungenkrebsprognose im frühstadium
EP2411003A4 (de) Verwendung von artemisininderivaten zur behandlung von asthma und chronisch obstruktiver lungenerkrankung (copd)
IL225262A0 (en) Methods and compositions for treating lung cancer
MX366130B (es) Inhibidores bivalentes de las proteinas iap y métodos terapéuticos que usan los mismos.
EP2340506A4 (de) Biomarker für lungenkrebs und verwendung
NZ731797A (en) Dna-pk inhibitors
EP2401406A4 (de) Verfahren für den nachweis von lungenkrebs
MX2011008799A (es) Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
WO2012125712A3 (en) Lung tumor classifier for current and former smokers
PL3329281T3 (pl) Nieinwazyjne wykrywanie nowotworu pochodzącego z tkanki poza płucem przy użyciu wydychanego powietrza
MX2019000091A (es) Metodo para el pronostico y tratamiento de cancer metastasico de los huesos originado de cancer de mama.
HUE045731T2 (hu) Mikro-RNS biomarkerek tüdõtumor diagnosztizálásához és/vagy kockázatának azonosításához
EP2694972B8 (de) Verfahren zur vorhersage und verbesserung der überlebenszeit von magenkrebspatienten
GB201608839D0 (en) Biomarkers useful for detectionof types, grades and stages of human breast cancer
EP3152560A4 (de) Nichtinvasiver nachweis von genmutationen bei lungenkrebspatienten
MX2019013468A (es) Metodos para tratar la enfermedad pulmonar obstructiva cronica usando benralizumab.
HUE054864T2 (hu) In vitro módszer tüdõrák diagnosztizálására
EP2921858A4 (de) Verfahren zur ermittlung von daten zur diagnose, prognose und klassifizierung von patienten mit chronischer obstruktiver lungenerkrankung (copd) und/oder lungenkrebs
PH12015500388A1 (en) Cancer diagnostic and therapeutic method targeting molecules expressed in cancer stem cells
MX2015017120A (es) Combinaciones para el tratamiento de cancer que comprende un inhibidor de la quinasa mps-1 y un inhibidor de la mitosis.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130204

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131118

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101AFI20131112BHEP

Ipc: G06F 19/20 20110101ALI20131112BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140201